Ishares Genomics Immunology Etf Widgets and Gadgets
| IDNA Etf | USD 23.58 0.42 1.75% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- IDNA iShares Genomics Immunology
- Latest Technical Pivots with Risk Controls - Stock Traders Daily
- IDNA 23.58 -0.42
- Low 23.56
- High 23.93
- Volume 19.8 K
- Alpha -0.16
- Beta 0.97
- Number Of Employees 403
- Beta 1.15
- Total Asset 170.27 M
- One Year Return 15.90 %
- Three Year Return (17.80) %
- Five Year Return (3.20) %
- Net Asset 170.27 M
- Last Dividend Paid 0.24
- Equity Positions Weight 99.56 %
- Accumulation Distribution 305.82
- Daily Balance Of Power (1.14)
- Rate Of Daily Change 0.98
- Day Median Price 23.74
- Day Typical Price 23.69
- Price Action Indicator (0.38)
- Period Momentum Indicator (0.42)
Market Snapshot Widget Example
DAX Index Germany | 20,426 0.13 | |
Taiwan Weighted Taiwan | 23,047 0.63 | |
PSI 20 Stock Portugal | 6,361 0.14 | |
CROBEX Croatia | 3,190 0.53 | |
Budapest SE Hungary | 80,540 0.01 | |
IDX 30 Jakarta Indonesia | 448.05 1.98 | |
ISEQ 20 Price Ireland | 1,648 0.39 | |
NYSE Comp USA | 19,769 0.61 | |
Tel Aviv 35 Israel | 2,335 0.04 | |
Coreshares Index Tracker South Afric | 1,084 0.28 | |
IPC MEXICO Mexico | 51,296 0.01 | |
KL Technology Malaysia | 62.34 0.1 | |
IBEX 35 Index Spain | 11,765 0.21 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,638 0.30 | |
SPASX Dividend Opportunities Australia | 1,688 0.43 | |
HNX 30 Vietnam | 485.48 0.81 | |
Bucharest BET-NG Romania | 1,247 1.10 | |
AMS Small Cap Netherlands | 1,242 0.75 | |
Oslo Exchange Mutual Norway | 1,407 0.21 | |
BEL Small Belgium | 8,052 0.28 | |
Basic Materials Brazil | 5,895 2.11 | |
Swiss Leader Price Switzerland | 1,941 0.25 | |
Fondo Mutuo ETF Chile | 1,404 0.67 | |
Athens General Comp Greece | 1,464 0.44 | |
Stock Exchange Of Thailand | 1,440 0.22 | |
PX Prague Stock Czech Repub | 1,722 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,641 0.02 | |
WIG 30 Poland | 2,900 0.81 | |
BIST Electricity Turkey | 510.98 0.62 |
Investing Ideas
In addition to having IShares Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare IShares Genomics
Compare IShares Genomics To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.